Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_241_библиотеки_им_акад_М_И_Перельмана
.pdf
151
European Society of Hypertension / В. Williams, G. Mancia, W. Spiering [et al.] //
Journal of Hypertension.- 2018. - Vol.36, № 10. - Р.1953-2041.
112. European Guidelines on cardiovascular disease prevention in clinical
practice (version 2012) / J. Perk, G. De Backer, H. Gohlke [et al.] // European Heart
Journal - 2012. - Vol.33, №13. - P.1635-1701.
113. European Heart Network and European Society of Cardiology / M.
Nichols, N. Townsend, P. Scarborough [et al.] // European Cardiovascular Disease
Statistics. - 2012. – 129 р.
114. Evaluating reliability of ultra-short ECG indices of heart rate variability in
diabetes mellitus patients / U. Nussinovitch, O. Cohen, K. Kaminer [et al.] // Journal
Diabetes Complications. - 2012. - Vol.26, № 5. - P. 450-453.
115. Exercise and physical activity in the prevention and treatment of
atherosclerotic cardiovascular disease: a statement from the Council on Clinical
Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council
on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)/
P.D. Thompson, D. Buchner, I.L. Pina [et al.] // Circulation.- 2003. - Vol.107, №24. -
P.109-116.
116. Fitness versus physical activity patterns in predicting mortality in men / J.
Myers, A. Kaykha, S. George [et al.] // American Journal of Medicine. - 2004. -
Vol.117, №12. - Р.912-918.
117. Global and regional burden of disease and risk factors 2001: systematic
analysis of population health data /A.D. Lopez, C.D. Mathers, M. Ezzati [et al] //
Lancet. - 2006. - Vol.367, №9524. - P.1447-1457.
118. Global burden of hypertension: analysis of worldwide data/ Р.М. Kearney,
M. Whelton, К. Reynolds [et al.] // Lancet. - 2005. - Vol.365, №9455. - Р.217-223.
119. Global status report on noncommunicable diseases 2010 / A. Alwan, T.
Armstrong, D. Bettcher [et al.] // World Health Organization. - 2011. - P.5-18.
120. Guidelines for the primary prevention of stroke: a guidline for healthcare
professionals from the American Heart Association/ American Stroke Association/ L.B.
https://t.me/med1917
152
Goldstein, C.D. Bushnell, R.J. Appel [et al.] // Stroke. - 2011. - Vol.42, № 2. - P. 517-
584.
121. Guidelines for treatment of overweight/obesity, 2006 / O.L. Svendsen ,
S.Toubro, J.M. Bruun [et al.] // Ugeskr Laeger. - 2006. - Vol.168. - №2. - P.180-182.
122. Hamer, M. Psychiatric hospital admissions, behavioral risk factors, and all-
cause mortality: the Scottish health survey / M. Hamer, E. Stamatakis, A. Steptoe //
Archives of Internal Medicine. – 2008. – Vol.168, № 22. – P. 2474-2479.
123. Heart rate is associated with increased risk of major cardiovascular events,
cardiovascular and all-cause death in patients with stable chronic cardiovascular
disease: an analysis of ONTARGET/TRANSCEND / E.M. Lonn, S. Rambihar, P. Gao
[et al.] // Clinical Research in Cardiology. - 2014. - Vol.103, № 2. - P.149-159.
124. Heart rate turbulence after ventricular and atrial premature beats in subjects
without structural heart disease/ K.S. Lindgren, T.H. Makikallio, T. Seppanen [et al.] //
Journal Cardiovascular Electrophysiology. - 2003. - Vol.14, №5. - P.447-452.
125. Heart rate turbulence following ventricular premature beats in healthy
controls/ W. Grimm, J. Sharkova, M. Christ [et al.] // Ann Noninvasive
Electrocardiology. - 2003. - Vol.8, №2. - P.127-131.
126. Heart Rate Turbulence: Standards of Measurement, Physiological
Interpretation, and Clinical Use. International Society for Holter and Noninvasive
Electrophysiology Consensus / A. Bauer, M. Malik, G. Schmidt [et al.] // Journals of the
American College of Cardiology. - 2008. - Vol.52, №17. - P.1353-1365.
127. Hennekens, C.H. Clinical and research challenges in risk factors for
cardiovascular diseases / C.H. Hennekens // European Heart Journal. - 2000. - Vol.21,
№23.- P.1917- 1921.
128. Idiopathic Left Bundle-Branch Block-Shaped Ventricular Tachycardia May
Originate Above the Pulmonary Valve/ C. Timmermans, L.M. Rodriguez, Crijns H.J.
[et al.] // Circulation. - 2003.- Vol.108, №16.- P.1960-1966.
129. Infusion needle radiofrequency ablation for treatment of refactory
ventricular arrhythmias / W.G. Stevenson, U.B. Tedrow, V. Reddy [et al.] // Journals of
the American College of Cardiology. - 2019. - Vol.73, №12. - P.1413-1425.
https://t.me/med1917
153
130. Laborde, S. Heart rate variability and cardiac vagal tone in
psychophysiological research–recommendations for experiment planning, data analysis,
and data reporting / S. Laborde, E. Mosley, J. F. Thayer // Frontiers in psychology. -
2017. - Vol.20, №8. - P.213.
131. Long-term prognostic value of resting heart rate in subjects with
prehypertension/ D.E. King, C.J. Everett, A.G. Mainous, H.A. Liszka // American
Journal Hypertension. - 2006. - Vol.19, №8. - P.796-800.
132. Mendis, S. Organizational update: the world health organization global
status report on noncommunicable diseases 2014; one more landmark step in the
combat against stroke and vascular disease / S. Mendis, S. Davis, B. Norrving // Stroke.
- 2015. - Vol.46, №5. -
Р.121-122.
133. Mental fatigue, work and sleep / T. Аkerstedt, A. Knutsson, P. Westerholm
[et al.] // Journal of Psychosomatic Research. - 2004. - Vol.57, №5. - P.415- 416.
134. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias/ S.
Chatterjee, C. Bavishi, P. Sardar [et al.] // The American journal of cardiology. - 2014. -
Vol.114, №7. - P.1049-1052.
135. Meta-analysis of ventricular premature complexes and their relation to
cardiac mortality in general populations / F. Ataklte, S. Erqou, J. Laukkanen, S.
Kaptoge // The American journal of cardiology. - 2013. - Vol.112, № 8. - P.1263-1270.
136. Non-linear relationships in associations of depression and anxiety with
alcohol use / B. Rodgers, A.E. Korten, A.F. Jorm [et al.] // Psychological Medicine. -
2000. - Vol.30, №2. - P.421-432.
137. Oral, Y. Prevalence of asymptomatic recurrences of atrial fibrillation after
sussessful radiofreguency catheter ablation / Y. Oral, S. Veerreddy // J. Cardiovascular
Electrophysiol. - 2004. - Vol.15, №8. – P. 920–924.
138. Palatini, P. Heart rate: a strong predictor of mortality in subjects with
coronary artery disease / P. Palatini // European Heart Journal. - 2005. - Vol. 26, №10. -
P.943- 945.
https://t.me/med1917
154
139. Perret-Guillaume, C. Heart rate as a risk factor for cardiovascular disease /
C. Perret-Guillaume, L. Joly, A. Benetos // Progress in cardiovascular diseases. - 2009. -
Vol.52, №1. – P.6-10.
140. Postema, P.G. The Measurement of the QT Interval / P.G. Postema, A.A.
Wilde. G. Pieter// Current Cardiology Reviews. - 2014. - Vol.10, №3.- P.287-294.
141. Prevalence, patterns and correlates of alcohol consumption and its
association with tobacco smokingamong Sri Lankan adults: a cross-sectional study/ P.
Katulanda, C. Ranasinghe, A. Rathnapala [et al.] // BMC Public Health. - 2014. - Vol.
17. - № 14.- P.612.
142. Reduction of cardiovascular risk by regression of electrocardiographic
markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor
Ramipril / J. Mathew, P. Sleight, E. Lonn [et al.] // Circulation. - 2001. - Vol.104, №14.
- P.1615-1621.
143. REFINE Investigators. Noninvasiverisk assessment early after a
myocardial infarction: the REFINE study / D.V. Exner, K.M. Kavanagh, M.P.
Slawnych [et al.] // Journal of the American College of Cardiology. - 2007. - Vol.50,
№24. - P. 2275-2284.
144. Ruilope, L.M. Left ventricular hypertrophy and clinical outcomes in
hypertensive patients / L.M. Ruilope, R.E. Schmieder // American journal of
hypertension. - 2008. - Vol.21, №.5. - Р.500-508.
145. Shaffer, F. An overview of heart rate variability metrics and norms / F.
Shaffer, J.P.Ginsberg // Frontiers in public health. - 2017. - Vol.28, №5. - P.258.
146. Singh, B.N. Morbidity and mortality in cardiovascular disorders: impact of
reduced heart rate / B.N. Singh // Journal of Cardiovascular Pharmacology and
Therapeutics. - 2001. - Vol.6, №4. - Р.313-31.
147. Single versus combined blood pressure components and risk for
cardiovascular disease: the Framingham Heart Study / S.S. Franklin, V.A. Lopez, N.D.
Wong [et al.] // Circulation. - 2009. - Vol.119, № 2. - Р. 243-250.
https://t.me/med1917
155
148. The impact of prevention on reducing the burden of cardiovascular disease/
R. Kahn, R.M. Robertson, R. Smith, D. Eddy // Circulation. - 2008. - Vol.118, № 5. -
P.576-585.
149. Time-domain T-wave alternans measured from Holter electrocardiograms
predicts cardiac mortality in patients with left ventricular dysfunction: A prospective
study/ K. Sakaki, T. Ikeda, Y. Miwa [et al] // Heart Rhythm. - 2009. - Vol. 6, № 3. -
P.332-337.
150. T-wave alternans predicts mortality in a population undergoing a clinically
in dicated exercise test / T. Nieminen, T. Lehtimaki, J. Viik [et al.] // European Heart
Journal. - 2007. - Vol.28, №19. - P.2332- 2337.
151. Vitasalo, M. Differention between LQT1 and LQT2. Patients and
Unaffected subjects using 24-hour electrocardiographic recordings / M. Vitasalo, L.
Oikarinen // American Journal Cardiology. - 2002. - Vol. 89, № 6. - P.679-685.
152. Watanabe, M.A. Heart Rate Turbulence: a 5-year review /M. A. Watanabe,
G. Schmidt // Heart Rhythm. - 2004. - Vol.1, №6. - P.732-738.
153. Wulsin, L.R. Do depressive symptoms increase the risk for the onset of
coronary disease & A sistematic quantitative review / L.R. Wulsin, B.M. Singal //
Psychosomatic medicine. - 2003. - Vol.5, № 2. - P.201-210.
154. Yildrir, A. Hypertension and arrhythmia: blood pressure control and
beyond/ А. Yildrir, М.К. Batur, А. Oto // Europace. - 2002. - Vol.4, №2. - Р.175-182.
155. Zheng, I. L-type Ca2+ channel mutation and T-wave alternans: а model
study/ I. Zheng, Е. Colleen // American Physiological Society Journal. - 2007. - 293(6),
H3480–H3489.
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана